Lite StrategyLITS +9.89%22 FCF Yield % is -34.10 as of Jun. 27, 2026. GuruFocus rates LITS with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 1,418 Biotechnology companies, Lite Strategy ranks worse than 78.84% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Lite Strategy FCF Yield % Related Terms
Lite Strategy FCF Yield % Historical Data
* Premium members only.
The historical data trend for Lite Strategy's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Lite Strategy's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lite Strategy FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lite Strategy's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Lite Strategy's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lite Strategy (LITS) has a FCF Yield % of -34.10 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lite Strategy and its competitors. According to the industry distribution chart, Lite Strategy ranks #1118 out of 1418 companies in the Biotechnology industry, placing it in the top 78.8%.
Is Lite Strategy's FCF Yield % too high?
Lite Strategy's current FCF Yield % is -34.10. Based on the distribution chart, Lite Strategy ranks #1118 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lite Strategy has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Lite Strategy's FCF Yield % compare to DARE and ALGS?
According to the Biotechnology industry distribution chart, Lite Strategy ranks #1118 out of 1418 companies for FCF Yield %. This places Lite Strategy in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lite Strategy and its competitors. Lite Strategy's current FCF Yield % is -34.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lite Strategy stock overvalued right now?
Lite Strategy (LITS) has a current FCF Yield % of -34.10. The current FCF Yield % is -34.10. Lite Strategy's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Lite Strategy (LITS), the current FCF Yield % is -34.10 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
22GF Score
Get the complete analysis for LITS
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LITS has been successfully added to your 
